PHK
LXRX icon

Point72 Hong Kong’s Lexicon Pharmaceuticals LXRX Stock Holding History

Point72 Hong Kong’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,603
Closed -$8K – 2228
2022
Q1 		$8K Buy
+3,603
New +$9.99K ﹤0.01% 1631
2021
Q2 		– Sell
-57
Closed – – 2194
2021
Q1 		$0 Buy
+57
New +$395 ﹤0.01% 2063
2019
Q1 		– Sell
-274
Closed -$2K – 1171
2018
Q4 		$2K Buy
+274
New +$2.22K ﹤0.01% 732
2018
Q2 		– Sell
-71
Closed -$1K – 1061
2018
Q1 		$1K Buy
+71
New +$657 ﹤0.01% 835
2017
Q4 		– Sell
-255
Closed -$3K – 984
2017
Q3 		$3K Buy
+255
New +$3.77K ﹤0.01% 616

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return